European advisory committee rejects AB Science’s masitinib marketing application for mastocytosis; shares down 26%

from Stock Market News http://ift.tt/2qt9Kb1’s-masitinib-marketing-application-for-mastocytosis;-shares-down-26-485543

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s